Cancer patients' willingness to answer survey questions about life expectancy.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
L J MackenzieA E Hall

Abstract

This study aimed to determine the proportion and characteristics of radiation oncology outpatients who were willing to answer questions about their life expectancy. A cross-sectional patient self-report survey was conducted using touch screen computers in Australian radiation oncology treatment centers. The primary outcome was the respondent's willingness to complete a survey subsection about life expectancy. Demographic and disease characteristics were also collected, and level of anxiety and depression was assessed using the Hospital Anxiety and Depression Scale. Of the 469 oncology outpatients who completed the survey, 327 (70 %; 95 % CI, 65 %, 74 %) indicated that they were willing to answer questions about life expectancy. Being female (p < 0.001), older (p < 0.05), born in Asia (p < 0.05), and being diagnosed with cancer types other than breast and prostate cancer (p < 0.01) were associated with lower odds of answering life expectancy questions. The opportunity to opt-out of survey questions about sensitive issues such as life expectancy is a feasible method for accessing important information about patient preferences while minimizing burden. Further research may be needed to improve acceptability of life expectancy rese...Continue Reading

References

Feb 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·S MooreyJ Bliss
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Nov 14, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P N ButowM J Boyer
Feb 17, 2001·Psycho-oncology·J ZaboraS Piantadosi
May 11, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Allison BoyesAfaf Girgis
Jun 6, 2002·Health Communication·Stan A KaplowitzWai Tat Chiu
Aug 28, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P M EllisM H N Tattersall
Dec 5, 2003·The Journal of Hospital Infection·C M PelloweUNKNOWN Guideline Development Group
Jan 31, 2004·Lancet·Lesley Fallowfield, Valerie Jenkins
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rebecca G HagertyMartin H N Tattersall
May 25, 2004·American Journal of Epidemiology·Kate M DunnClare Jinks
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rebecca G HagertyMartin H N Tattersall
Aug 30, 2005·Journal of Pain and Symptom Management·Josephine M ClaytonMartin H N Tattersall
Sep 15, 2005·BMJ : British Medical Journal·Cornelia JunghansMelvyn Jones
Feb 28, 2006·Journal of Palliative Medicine·David Casarett
Nov 4, 2006·The Lancet Oncology·Antonella Surbone
May 18, 2007·Journal of Genetic Counseling·Francisco J DominguezKevin S Hughes
Sep 6, 2007·The Medical Journal of Australia·Josephine M ClaytonUNKNOWN Thoracic Society of Australia and New Zealand
Jul 22, 2008·The Lancet Oncology·Michel P ColemanUNKNOWN CONCORD Working Group
Oct 9, 2008·JAMA : the Journal of the American Medical Association·Alexi A WrightHolly G Prigerson
Feb 5, 2009·Japanese Journal of Clinical Oncology·Maiko Fujimori, Yosuke Uchitomi
Sep 19, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C L PaulG Webb
May 5, 2010·Journal of Medical Ethics·Kerith SharkeyPenelope Schofield
Feb 26, 2011·Psycho-oncology·D MitchisonD Goldstein

❮ Previous
Next ❯

Software Mentioned

Digivey

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Managed Care
Lumie KawasakiKaren N DeSalvo
Health Reports
Julie St-ArnaudPatricia Tully
The Journal of Nutrition
S WATANABE
© 2021 Meta ULC. All rights reserved